January 19, 2025 - 22:11

Investors brace for a volatile ride as President-elect Donald Trump’s second term gets underway on Monday, bringing the promise of significant policy shifts. Market analysts are closely examining which sectors may emerge as winners and losers under the incoming administration.
Historically, Trump's policies have had a profound impact on various industries, with energy, defense, and financial sectors often benefiting from his administration's initiatives. The anticipated focus on deregulation and tax cuts is expected to give a boost to these areas, attracting investor interest. Conversely, sectors such as technology and healthcare may face headwinds due to potential regulatory changes and shifts in trade policies.
As the new term unfolds, investors are advised to stay alert and agile, ready to adapt their strategies in response to the unfolding political landscape. The uncertainty surrounding Trump's agenda, combined with the ongoing economic recovery, suggests that volatility will be a defining feature of the markets in the coming months.
February 28, 2026 - 02:28
Why Axos Financial (AX) Shares Are Sliding TodayShares of Axos Financial experienced a sharp decline in Thursday`s trading session, mirroring a broader downturn across the financial sector. The digital bank`s stock fell nearly 9% following the...
February 27, 2026 - 23:14
House Finance Committee advances millionaires tax bill to full voteA landmark proposal to institute the first-ever income tax in Washington state has cleared a critical hurdle. The House Finance Committee voted to advance the bill, setting the stage for a full...
February 27, 2026 - 05:38
Super Group (SGHC) Limited (SGHC) Reports Financial Results For Fourth Quarter and Full Year 2025Super Group (SGHC) Limited, the parent company of leading global online sports betting and gaming brands, has released its financial results for the fourth quarter and full year ended December 31,...
February 26, 2026 - 20:17
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent ProgressCRANBURY, N.J., February 26, 2026—Rocket Pharmaceuticals, a late-stage biotechnology firm, has released its financial and operational results for the fourth quarter and full year ending December...